Rockwell Medical, Inc.
RMTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $16 | $16 | $19 | $25 |
| % Growth | -0.9% | -15% | -23.3% | – |
| Cost of Goods Sold | $14 | $14 | $16 | $21 |
| Gross Profit | $2 | $3 | $3 | $4 |
| % Margin | 14.3% | 15.6% | 16.1% | 14.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $3 | $4 | $3 |
| SG&A Expenses | $4 | $4 | $4 | $4 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $4 | $4 | $4 |
| Operating Income | -$2 | -$1 | -$1 | -$1 |
| % Margin | -9.9% | -8.4% | -7.2% | -2.1% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$2 | -$1 | -$2 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$1 | -$2 | -$1 |
| % Margin | -11% | -9.3% | -8% | -3.1% |
| EPS | -0.05 | -0.044 | -0.044 | -0.023 |
| % Growth | -14.9% | 2% | -93% | – |
| EPS Diluted | -0.05 | -0.044 | -0.044 | -0.023 |
| Weighted Avg Shares Out | 36 | 34 | 34 | 33 |
| Weighted Avg Shares Out Dil | 36 | 34 | 34 | 33 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | -$1 | -$1 | -$1 | $0 |
| % Margin | -8.8% | -4.1% | -3.7% | 0.3% |